OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials
Zixin Wu, Guishuai Lv, Fuxue Xing, et al.
Cancer Letters (2023) Vol. 571, pp. 216348-216348
Closed Access | Times Cited: 14
Zixin Wu, Guishuai Lv, Fuxue Xing, et al.
Cancer Letters (2023) Vol. 571, pp. 216348-216348
Closed Access | Times Cited: 14
Showing 14 citing articles:
Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
Yuhong Wang, Pei Pei, Kai Yang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 16
Yuhong Wang, Pei Pei, Kai Yang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 16
Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy
Qingling Feng, Yue Sun, Zhe Yang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Qingling Feng, Yue Sun, Zhe Yang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease
Yun Mao, Huilan Chen, Weihan Zhu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 883-894
Open Access
Yun Mao, Huilan Chen, Weihan Zhu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 883-894
Open Access
A novel overtone peak self-referencing fluorescent sensor based on a bipyridine-linked covalent organic framework for highly sensitive copper ion detection
Tongfu Huang, Wei Xiong, Fusheng Liao, et al.
Analytical Methods (2025)
Closed Access
Tongfu Huang, Wei Xiong, Fusheng Liao, et al.
Analytical Methods (2025)
Closed Access
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Cancer Letters (2024) Vol. 598, pp. 217102-217102
Open Access | Times Cited: 4
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Cancer Letters (2024) Vol. 598, pp. 217102-217102
Open Access | Times Cited: 4
Biodegradable copper-iodide clusters modulate mitochondrial function and suppress tumor growth under ultralow-dose X-ray irradiation
Xiaoqian Ma, Nuo Lin, Feng Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Xiaoqian Ma, Nuo Lin, Feng Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Cuproptosis: a promising new target for breast cancer therapy
Qianqian Jiang, Fei Tong, Yun Xu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Qianqian Jiang, Fei Tong, Yun Xu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma
Erva Özkan, Filiz Bakar‐Ates
Journal of Cancer Research and Clinical Oncology (2023)
Closed Access | Times Cited: 4
Erva Özkan, Filiz Bakar‐Ates
Journal of Cancer Research and Clinical Oncology (2023)
Closed Access | Times Cited: 4
Alterations of Nutrient Elements in Hepatocellular Carcinoma Patients Treated with Atezolizumab-Bevacizumab
Shuyue Xiao, Xiaohui Huang, S H Liu, et al.
Nutrition and Cancer (2024) Vol. 77, Iss. 2, pp. 244-251
Closed Access
Shuyue Xiao, Xiaohui Huang, S H Liu, et al.
Nutrition and Cancer (2024) Vol. 77, Iss. 2, pp. 244-251
Closed Access
BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis
Yanxing Mai, Zhongzhong Ji, Yujing Tan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Yanxing Mai, Zhongzhong Ji, Yujing Tan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer
Xiangdong Liu, Wanqiu Zhang, Shaozhong Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Xiangdong Liu, Wanqiu Zhang, Shaozhong Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Construction of a Novel Cuproptosis-Related ceRNA Network-SNHG3/miR-1306-5p/PDHA1 and Identification of SNHG3 as a Prognostic Biomarker in Hepatocellular Carcinoma
Yong Pan, Yiru Zhang, Xiaodan Hu, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38690-38703
Open Access | Times Cited: 1
Yong Pan, Yiru Zhang, Xiaodan Hu, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38690-38703
Open Access | Times Cited: 1
Bioactivity and computational studies on the induction of urease inhibition by three Cu(II) complexes with a fluorinated Schiff base and different secondary ligands
Wei Zhang, Hu Wang, Chao Ding, et al.
Inorganic Chemistry Communications (2023) Vol. 159, pp. 111780-111780
Closed Access | Times Cited: 1
Wei Zhang, Hu Wang, Chao Ding, et al.
Inorganic Chemistry Communications (2023) Vol. 159, pp. 111780-111780
Closed Access | Times Cited: 1
Editorial: Different cell death modes in cancer treatment
Zhaoshi Bai, Jie Dou, Tareq Saleh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
Zhaoshi Bai, Jie Dou, Tareq Saleh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
